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ABSTRACT
Hematopoietic stem cells (HSCs) transplantation was introduced as curative treatment for various diseases. 
Cryopreservation of HSCs is crucial for long term storage and maintenance of cellular quality; however, it has been 
reported that cryopreservation itself causes oxidative stress-driven apoptosis and cell loss. This study investigated 
impact of supplementing N-acetylcysteine (NAC) as antioxidant during cryopreservation on viability and oxidative 
stress in HSCs. HSCs were isolated from murine bone marrow, cultured in HSCs growth media and cryopreserved (1×106 
cells per vial) together with 10% DMSO and NAC (0, 0.25, 0.5 or 2.0 µM) for 48 h, 2 weeks or 8 weeks at -196°C using 
controlled-rate-freezing technique. Cell viability and oxidative stress in cryopreserved cells were analysed at each time-
point. Cell viability was significantly reduced (p<0.05) following cryopreservation as compared to pre-cryopreservation. 
NAC supplementation significantly increased cell viability (p<0.05) after 48 h cryopreservation at 0.5 µM and 2.0 µM 
and after 2 weeks cryopreservation at 0.25 µM compared to the controls. Cryopreservation significantly enhanced GSH 
level (p<0.05) and reduced MDA level (p<0.05) without affecting SOD activity and PC level in HSCs compared to pre-
cryopreservation. NAC supplementation significantly increased GSH level at 0.25 µM in cryopreserved HSCs compared 
to control. In conclusion, NAC supplementation during cryopreservation showed potential in minimizing cryoinjury by 
promoting cell viability, increasing antioxidant capacity and reducing oxidative damage in HSCs, however these effects 
are influenced by both durations of cryopreservation and NAC concentration.
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ABSTRAK
Pemindahan sel stem hematopoietik (SSH) telah diperkenalkan sebagai rawatan pelbagai penyakit. Pengawetan krio 
SSH adalah penting untuk penyimpanan dan pemeliharaan kualiti SSH, namun pengawetan krio dilaporkan berupaya 
mengaruh apoptosis dan penurunan keviabelan sel akibat tekanan oksidatif. Kajian ini telah mengkaji kesan suplementasi 
N-asetilsistien (NAC) sebagai antioksidan semasa pengawetan krio terhadap keviabelan dan tekanan oksidatif SSH. SSH 
diisolasi daripada sum-sum tulang mencit, dikulturkan di dalam media pengkulturan SSH dan seterusnya diawet krio 
(1×106 sel per vial) dengan penambahan 10% DMSO dan NAC (0 µM, 0.25 µM, 0.5 µM atau 2.0 µM) selama 48 jam, 2 
minggu atau 8 minggu pada suhu -196°C. Keviabelan sel dan tekanan oksidatif ditentukan ke atas SSH pada setiap tempoh 
pengawetan krio. Keviabelan sel menurun secara signifikan (p<0.05) selepas pengawetan krio berbanding dengan pra-
pengawetan krio. Suplementasi NAC telah meningkatkan keviabelan sel secara ketara (p<0.05) selepas pengawetan krio 
selama 48 jam pada kepekatan 0.5 µM dan 2.0 µM dan juga selepas 2 minggu pengawetan krio pada kepekatan 0.25 
µM berbanding kawalan. Pengawetan krio memberi kesan peningkatan aras GSH (p<0.05) dan penurunan aras MDA 
(p<0.05) tanpa memberi kesan yang signifikan terhadap aras SOD dan PC berbanding pra-pengawetan krio. Suplementasi 
NAC meningkatkan aras GSH secara signifikan (p<0.05) pada kepekatan 0.25 µM dalam SSH yang dikrio awet berbanding 
kawalan. Secara kesimpulannya, suplementasi NAC semasa pengawetan krio berpotensi meningkatkan keviabelan sel dan 
kapasiti antioksidan serta mengurangkan kesan kerosakan oksidatif, tetapi kesan ini adalah dipengaruhi oleh jangka 
masa pengawetan krio dan kepekatan NAC yang digunakan.
Kata kunci: N-asetilsistien; pengawetan krio; sel stem hematopoietik; tekanan oksidatif
INTRODUCTION
Hematopoietic stem cells (HSCs) are a group of cells 
isolated from blood or bone marrow; with pluripotency 
and self-renewal capacity that allow generation of an 
entire hematopoietic system (Ng & Alexander 2017). 
Pluripotency refers to the capacity of a single HSC to 
generate multiple types of functional and matured cells 
(Seita & Weissman 2010). Hematopoietic stem cell 
transplantation is a favorable treatment option for diseases 
of malignant and benign tumors, hematological disorder 
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and inherited diseases (Hatzimichael & Tuthill 2010). The 
first Malaysian bone marrow-derived HSCs transplantation 
was performed in University Malaya on a child in 1987; 
followed by in an adult patient in 1993 (Fadilah et 
al. 2008). Sources of HSCs for transplantation include 
bone marrow aspirates, mobilized peripheral blood and 
umbilical cord blood (Panch et al. 2017). The International 
Bone Marrow Transplant Registry (IBMTR) reported that 
after 1998, it is estimated that 20% of young patient stem 
cell transplantation was achieved solely using cord blood-
derived HSCs transplantations (Rocha & Gluckman 2006).
 In certain circumstances, cryopreservation of the 
stem cells is necessary when transplantation cannot be 
done immediately after stem cell harvest. However, 
cryopreservation may deleteriously affect the quality 
and quantity of preserved stem cells in terms of viability 
and functionality (Pal et al. 2008; Reubinoff et al. 
2001; Vosganian et al. 2012). Despite the availability of 
recommended guidelines for HSCs cryopreservation, a 
number of limitations associated with the technique of 
cryopreservation are becoming a major concern. Freeze-
thaw cycle in stem cells causes cellular damages, due to ice 
nucleation and dehydration. Furthermore, cryopreservation 
itself induce microtubule depolymerisation in these cells 
which impairs their ability to maintain a functional 
spindle after thawing (Tatone et al. 2010). Moreover, 
cryopreservation may also promote oxidative stress in 
these cells through osmotic stress and increased reactive 
oxygen species (ROS) production, all of which reduce 
the stem cell functionality and increase macromolecule 
damages such as lipid peroxidation, protein oxidation and 
DNA damage. 
 Isolation of HSCs from its bone marrow origin causes 
changes in stem cell niche. HSCs niche maintenance relies 
on a few factors including adhesion molecules, cytokines 
and growth factor, microenvironment oxygen concentration 
as well as other gene regulators (Matsumoto et al. 2011). 
HSCs are controlled by a hypoxic microenvironment 
niche with ~5% oxygen saturation. However, there is 
an immediate change in their microenvironment during 
the isolation procedure, given that ex vivo cultures have 
normoxic oxygen saturation (Abdul Hamid et al. 2018) 
that can promote oxidative stress and cause damage to 
cellular macromolecules; affecting HSCs survivability 
and functionality (Abdul Hamid et al. 2018; Shaban 
et al. 2017). To overcome these limitations, the use of 
antioxidant supplementation is therefore recommended. 
Antioxidant supplementation prior to cryopreservation 
is known to reduce oxidative stress and damage. 
Antioxidants protect cellular constituents from oxidative 
stress by neutralizing free radicals and terminating the 
oxidative chain reaction in mitochondrial membrane 
(Kotahri et al. 2010). They can also help improving cellular 
survival, potency and differentiation of HSCs (Shaban et 
al. 2017). N-acetylcysteine (NAC) is an acetylated cysteine 
residue containing sulphur, commonly used to inhibit 
ROS-induced cellular damage and apoptosis (Berniakovich 
et al. 2012). Studies conducted by Abdul Hamid et al. 
(2018), Fan et al. (2008) and Liu et al. (2012) all showed 
that NAC supplementation exhibited significant protective 
effect in maintaining cultured HSCs in ex vivo condition. 
Application of NAC to maintain HSCs survival and potency 
ability following cryopreservation should be investigated 
to improve the HSCs quality for transplantation use. 
Hence, this study is conducted to investigate the effect 
of NAC supplementation on cryopreservation of HSCs by 
evaluating their viability and oxidative stress markers at 
different cryopreservation time points of 48 h, 2 weeks 
and 8 weeks.
METHODS AND MATERIALS
MATERIALS
NAC was purchased from Sigma-Aldrich (Sigma Grade, 
≥ 99% (TLC) and was prepared by dissolving powder in 
phosphate buffer saline (PBS). NAC stock solution was 
filtered using a filter with pore size 0.22 μM under the 
laminar flow and the working solution was prepared via 
serial dilutions prior to experiments. 
EXPERIMENTAL PROTOCOLS
All procedures involving the use of laboratory animals was 
reviewed and approved by UKM Animal Ethics Committee 
(Ethics Approval Number: FSK/2017/ZARIYANTEY/22-
NOV./889-NOV.-2017-JULY-2019-AR-CAT2). A total 
of 15 mice were used throughout the study. HSCs were 
harvested from bone marrow of ICR mouse as previously 
described (Boltz-Nitulescu et al. 1987). Briefly, mouse was 
first sacrificed using cervical dislocation and the stem cells 
were isolated in complete DMEM medium (supplemented 
with 10% fetus bovine serum (FBS) and 2% Pen-Strep). 
Cell viability enumeration was measured using Trypan 
Blue exclusion method. Viable HSCs were cultured in same 
DMEM medium and cell growth overnight were measured 
after 24 h incubation at 37°C in 5% CO2 incubator. Stem 
cell density for each cryopreservation sample was adjusted 
to 1×106 cells/mL. For each cryopreservation, 10% DMSO 
was added as cryoprotectant and NAC (0.25, 0.5 and 2.0 
μM) was supplemented accordingly. NAC-free solution was 
used as vehicle control supplementation (Abdul Hamid 
et al. 2018). Total volume of suspension in each cryovial 
was 1.5 mL. The cryovials were frozen using controlled-
rate-freezing technique inside Planer Kryo 550-16 before 
storage in liquid nitrogen tank at Pusat Darah Negara 
(Malaysia). Ambient temperature of the sample was 
initially lowered to 0°C for 5 min before -2°C reduction 
per min to -30°C, then -2°C reduction per min to -60°C 
and finally by -4°C reduction per min to -100°C and held 
at -100°C until the sample was removed and placed in 
liquid nitrogen tank. Duration of cryopreservation duration 
was set up at three different time-points i.e. 48 h, 2 weeks 
and 8 weeks. Upon completion of each cryopreservation 
time-point, the cryopreserved cells were thawed and 
resuspended in DMEM medium for viability analysis 
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using Trypan Blue exclusion. Cell lysates were prepared 
from cryopreserved cells for analysis of oxidative stress 
markers such as glutathione (GSH), superoxide dismutase 
(SOD), malondialdehyde (MDA) and protein carbonyl (PC), 
respectively. Each parameter was analyzed using three 
independent biological replicates.
DETERMINATION OF GLUTATHIONE (GSH) LEVEL AND 
SUPEROXIDE DISMUTASE (SOD) ACTIVITY
Following 48 h, 2 weeks and 8 weeks of cryopreservation, 
cell lysates were prepared and protein level was determined 
using Bradford assay prior to antioxidant analyses. Level 
of GSH in cells was measured using spectrophotometer. 
GSH plays critical roles in protecting cells from oxidative 
damage and the toxicity of xenobiotic electrophiles. 
Measurements of SOD activity was based on Beyer and 
Fridovich (1987). SOD acts as first-line antioxidant defense. 
In this assay, photon from light source activates riboflavin 
which oxidizes L-Metionin to generate superoxide and 
resulting superoxide reacts with SOD enzyme in the sample 
and lower nitrotetrazolium blue (NBT) reduction. Reduction 
of NBT causes formation of the purple-colored formazan 
measurable spectrophotometrically at 560 nm wavelength. 
DETERMINATION OF MALONDIALDEHYDE (MDA) AND 
PROTEIN CARBONYL (PC) LEVELS
For MDA assay, cryopreserved cells were collected, 
lysed and centrifuged at 1000 rpm for 10 min. All the 
supernatants were collected, and thiobarbituric acid 
(TBA) reagent was added into each vial containing 100 
μL of supernatant samples. All vials were incubated for 
60 min at 95ºC and were left in room temperature for 10 
min. 200 μL of supernatant (containing MDA-TBA adduct) 
was pipetted into 96 wells microtiter plate for analysis 
and absorbance were measured at 532 nm wavelength. 
For protein carbonyl assay, cells were similarly collected, 
sonicated in 2 mL of buffer solution and centrifuged at 
1000 rpm for 15 min at 4°C. 50 μL of supernatant was 
transferred into microcentrifuge tubes and was added with 
50 μL trichloroacetic acid (TCA) prior to centrifugation at 
1000 rpm for 5 min at 4°C. Supernatant were discarded and 
500 μL dinitrophenylhydrazine (DNPH) was added into each 
tube and were incubated in dark for 1 h. The tubes were 
centrifuged again at 1000 rpm for 5 min at 4ºC. Supernatant 
was discarded and the cell pellets were resuspended in 1 
mL 10% w/v TCA. All tubes were put in the ice for 5 min 
and centrifuged. All cell pellets were resuspended with 1 
mL 5M urea after centrifugation and the tubes were kept in 
water bath (37°C) for 15 min. The tubes were centrifuged at 
1000 rpm for 5 min at 4ºC and 200 μL of supernatant were 
pipetted into 96 wells microtiter plate for measurement of 
absorbance at 360 nm wavelength. 
STATISTICAL ANALYSIS
All results are reported as mean ± standard error of mean 
(SEM) from three independent experiments. The results 
were analyzed using one-way analysis of variance (ANOVA) 
and Tukey’s post-hoc test with p < 0.05 considered as 
statistically significant.
RESULTS
EFFECT OF NAC SUPPLEMENTATION IN   
CRYOPRESERVATION ON CELL VIABILITY OF HSCS
Analysis of HSCs viability after cryopreservation at 
temperature of -196°C for 48 h, 2 weeks and 8 weeks 
was enumerated using trypan blue exclusion method. 
Cryopreservation at -196°C caused a significant reduction 
(p<0.05) in cell viability in all experimental groups after 48 
h, 2 weeks and 8 weeks as compared to pre-cryopreserved 
group. However, as shown in Figure 1, supplementation 
with NAC for 48 h caused a significant increase (p<0.05) 
in cell viability at 0.5 μM (3.6±0.29×105) and 2.0 μM 
(4.07±0.21×105), respectively, as compared to the control 
group (1.93±0.12×105). After 2-weeks cryopreservation, 
a significant increase (p<0.05) in cell viability was 
only noted between 0.25 μM NAC-supplemented group 
(8.18±0.14×105) and the control group (5.34±0.12×105). 
Meanwhile, no significant difference in cell viability for 
all NAC-supplemented groups compared to the control 
group was observed after 8 weeks cryopreservation. 
EFFECT OF NAC SUPPLEMENTATION IN  
CRYOPRESERVATION ON GSH LEVEL OF HSCS
Analysis of GSH level in pre-cryopreserved and 
cryopreserved groups  wi th  and wi thout  NAC 
supplementation are shown in Figure 2. The results 
showed that there is a significant increase (p<0.05) in GSH 
level for cryopreserved cells without NAC supplementation 
(control) and cells supplemented with 0.5 μM NAC after 48 
h as compared to pre-cryopreservation group (Pre). The 
level of GSH for control and 0.5 μM NAC-supplemented 
groups was 1.07±0.09 mmol/mg and 1.04±0.003 mmol/
mg, respectively, as compared to 0.85±0.003 mmol/mg 
for pre-cryopreservation group. Meanwhile, there is no 
significant difference in GSH level for cryopreserved 
cells with NAC at other concentrations (0.25 μM and 2.0 
μM) as compared to pre-cryopreservation group (Pre). 
Comparison within cryopreservation groups showed that 
there was no significant difference in GSH level in cells 
with NAC-supplemented groups (0.25 μM, 0.5 μM and 
2.0 μM) as compared to control group (1.07±0.08 mmol/
mg). Analysis of HSCs after 2 weeks cryopreservation 
showed a significant increase (p<0.05) in GSH level 
for all NAC-supplemented groups including control 
group compared to pre-cryopreserved group (Pre). The 
notable GSH levels were 1.54±0.01 mmol/mg (control), 
1.38±0.01 mmol/mg (0.25 μM), 1.42±0.00 mmol/mg 
(0.5 μM) and 1.48±0.01 mmol/mg (2.0 μM) compared 
to pre-cryopreservation group (0.85±0.003 mmol/mg). 
However, there is no significant difference in the GSH 
level of NAC-supplemented cryopreserved HSCs compared 
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FIGURE 1. Effect of NAC supplementation on the viability of HSCs after 48 h (A), 2 weeks (B) and 
8 weeks (C) cryopreservation. Each data is obtained from three different experiments (n=3). Data 
is expressed as mean ± standard error of mean (SEM). aSignificant different (p<0.05) against pre-
cryopreservation group (Pre); bSignificant different against control group (0 μM)
FIGURE 2. Effect of NAC supplementation on the GSH level of HSCs after 48 h (A), 2 weeks (B) and 
8 weeks (C) cryopreservation. Each data is obtained from three different experiments (n=3). Data 
is expressed as mean ± standard error of mean (SEM). aSignificant different (p<0.05) against pre-
cryopreservation group (Pre); bSignificant different against control group (0 μM)
to the control group. Meanwhile, a significant increase 
(p<0.05) of GSH level were observed after 8 weeks 
of cryopreservation compared to pre-cryopreserved 
group. GSH levels were as follows: 1.44±0.003 mmol/
mg (control), 2.12±0.2 mmol/mg (0.25 μM), 1.40±0.02 
mmol/mg (0.5 μM) and 1.4±0.01 mmol/mg (2.0 μM) 
compared to pre-cryopreserved group (0.85±0.003 mmol/
mg). However, when comparing the GSH level between 
NAC-supplemented group against control group during 
cryopreservation state, a significant increase (p<0.05) of 
GSH level was only noted at 0.25 μM NAC.
EFFECT OF NAC SUPPLEMENTATION IN  
CRYOPRESERVATION TOWARDS SOD ACTIVITY OF HSCS
After 48 h cryopreservation, no significant difference 
was seen in SOD activity between pre-cryopreserved (Pre) 
and cryopreserved groups; along with no remarkable 
effect of NAC on GSH levels during cryopreservation 
state (Figure 3). Similar finding was also noted after 2 
weeks cryopreservation with exception for NAC at 0.5 
μM which caused significant reduction (p<0.05) of SOD 
activity (38±2.65 U/min/mg) compared to control group 
(76±6.81 U/min/mg). Meanwhile, a significant increase 
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(p<0.05) in SOD activity for cells cryopreserved in the 
presence of NAC at 0.5 μM (128±17.84 U/min/mg) and 
2.0 μM (151±22.23 U/min/mg) for 8 weeks was noted 
as compared to pre-cryopreservation group (52±7.53 U/
min/mg). However, there was no significant difference in 
SOD activity between NAC-supplemented groups (0.25, 0.5 
and 2.0 μM) compared to the control group after 8 weeks 
cryopreservation.
EFFECT OF NAC SUPPLEMENTATION IN  
CRYOPRESERVATION TOWARDS MDA LEVEL OF HSCS
After 48 h cryopreservation, there is no significant 
difference in MDA level between pre-cryopreserved group 
(Pre) and cryopreserved group for all NAC concentration 
(Figure 4). There is also no significant difference in MDA 
level seen at all NAC concentrations (0.25, 0.5 and 2.0 μM) 
compared to the control group after 48 h cryopreservation. 
However, a significant reduction (p<0.05) in MDA 
level between cryopreserved and pre-cryopreservation 
groups were noted following 2 weeks and 8 weeks 
cryopreservation; although the effect of NAC on the MDA 
levels during cryopreservation state at these time-points 
were not significant. MDA level in pre-cryopreservation 
group was 7.67±0.55 nmol/mg; followed by 1.60±0.10 
nmol/g (control), 2.57±1.11 nmol/g (0.25 μM), 4.17±0.45 
nmol/g (0.5 μM) and 2.47±0.74 nmol/g (2.0 μM) after 4 
weeks cryopreservation. As for 8 weeks cryopreservation 
time-point, the measured MDA levels for control and 
NAC-added groups (0.25, 0.5 and 2.0 μM) were 2.43±0.23 
nmol/g, 1.63±0.27 nmol/g, 4.3±0.83 nmol/g and 1.63±0.26 
nmol/g, respectively. 
EFFECT OF NAC SUPPLEMENTATION IN  
CRYOPRESERVATION TOWARDS PC LEVEL OF HSCS
A significant increase (p<0.05) in the PC level for 
cryopreserved cells with and without NAC supplementation 
compared to pre-cryopreservation group (Pre) after 48 h 
of cryopreservation (Figure 5) was noted. Level of PC in 
pre-cryopreserved group was 4.86±0.08 nmol/g; while 
the cryopreserved group recorded PC levels of 5.56±0.03 
nmol/g (control), 5.3±0.06 nmol/g (0.25 μM), 5.76±0.03 
nmol/g (0.5 μM) and 4.66±0.03 nmol/g (2.0 μM), 
respectively. However, there is no significant difference 
in PC level between cryopreserved HSCs that received NAC 
supplementation (0.25, 0.5 and 2.0 μM) and the control 
group (0 μM).
 Analysis on HSCs after 2 weeks cryopreservation 
showed a significant increase in PC level for HSCs 
underwent cryopreservation than the HSCs in pre-
cryopreservation group (Pre). The PC level for pre-
cryopreservation group was 4.86±0.08 nmol/mg compared 
to groups receiving 0.25 μM, 0.5 μM and 2.0 μM NAC 
supplementation (20.70±0.46 nmol/g, 22.50±1.85 nmol/g 
and 21.37±2.25 nmol/g; respectively) and control group 
(21.73±0.44 nmol/g). No significant difference was seen 
in PC level within cryopreserved group in between NAC-
supplemented (0.25 μM, 0.5 μM and 2.0 μM) and control 
groups. A significant increase (p<0.05) of PC levels were 
also noted between 8 weeks cryopreserved HSCs compared 
to the pre-cryopreserved group (Pre). The levels of PC for 
cryopreserved HSCs were at 22.27±1.28 nmol/g (control), 
28.33±2.87 nmol/g (0.25 μM), 22.77±1.24 nmol/g (0.5 μM) 
and 17.70±1.62 nmol/g (2.0 μM) compared to 4.86±0.08 
nmol/g for pre-cryopreservation group. Meanwhile, 
FIGURE 3. Effect of NAC supplementation on the SOD activity of HSCs after 48 h (A), 2 weeks (B) 
and 8 weeks (C) cryopreservation. Each data is obtained from three different experiments (n=3). Data 
is expressed as mean ± standard error of mean (SEM). aSignificant different (p<0.05) against pre-
cryopreservation group (Pre); bSignificant different against control group (0 μM)
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there is no significant difference in PC level between NAC 
supplemented group (0.25, 0.5 and 2.0) compared to the 
cryopreserved control group. 
DISCUSSION
Usage of HSCs in clinical transplantation is one of the 
most favourable treatment options for haematological-
related disorders, lymphoid cancers and other variety of 
disorders (Copelan 2006). Thus, cryopreservation plays 
an important role in both autologous and allogeneic HSCs 
transplantation. However, cryopreservation also causes 
a potential cellular damage to the cryopreserved cells 
via oxidative stress. This event may affect the cellular 
viability, the stemness property and the functionality 
of cells to proliferate and differentiate (Djuwantono et 
FIGURE 4. Effect of NAC supplementation on the MDA level of HSCs after 48 h (A), 2 weeks (B) and 8 weeks 
(C) cryopreservation. Each data is obtained from three different experiments (n=3). Data is expressed as mean ± 
standard error of mean (SEM). aSignificant different (p<0.05) against pre-cryopreservation group (Pre)
FIGURE 5. Effect of NAC supplementation on the PC level of HSCs after 48 h (A), 2 weeks (B) and 8 weeks 
(C) cryopreservation. Each data is obtained from three different experiments (n=3). Data is expressed as 
mean ± standard error of mean (SEM). aSignificant different (p<0.05) against pre-cryopreservation group 
(Pre); bSignificant different against control group (0 μM)
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al. 2011; Maraldi et al. 2015). Hence, the usage of bio-
oxidant supplements in cryopreservation medium offers an 
alternative solution to overcome these limitations (Motta 
et al. 2010). Thus, this study was conducted to investigate 
the effect of N-acetylcysteine (NAC) supplementation on 
the cryopreserved HSCs by evaluating cellular viability 
and oxidative stress after 48 h, 2 weeks and 8 weeks 
cryopreservation at -196°C. 
 Previously, NAC showed protective effect against 
oxidative-stress mediated cellular damage during ex vivo 
maintenance of cultured HSPCs by reducing cell loss, 
lowering oxidative stress and maintaining the repopulation 
capacity of HSCs into committed progenitors (Abdul 
Hamid et al. 2018, 2014; Chin et al. 2018; Liu et al 2012). 
However, the cryopreservative role of NAC for preservation 
of HSCs remains unexplored. Since the present study is 
among the few studies concerning NAC utility for HSCs 
cryopreservation with incorporation of oxidative stress 
status, the three time-points were selected at the current 
stage of the study to identify the time-points effects from 
hours up to months. There is no standard recommendation 
for HSCs cryopreservation time-points; although a number 
of studies reported that the cells can be stored up to years 
at -196°C (Berz et al. 2007). In term of clinical practices, 
cryopreservation is recommended when transplantation is 
not doable within 72 h from the period of HSCs collection 
(Berz et al. 2007). However, in the context of research 
application, the ability to cryopreserve the HSCs without 
compromising its property is also crucial to allow optimal 
preservation and to minimize the need for fresh isolation 
of the sample for every usage. This will improve usability 
of HSCs for research application. 
 Based on the results, it was shown that cryopreservation 
caused a significant loss of cellular viability after 48 h, 2 
weeks and 8 weeks for cryopreserved HSCs either with or 
without NAC. Many studies showed that cryopreservation 
is responsible for oxidative stress in most eukaryotic cells 
through cell membrane damage, mitochondrial dysfunction 
and variations in the oxidative metabolism during the cell 
survival (Tatone et al. 2010). Hence, it is speculated that 
the significant cell loss during all three time-points of 
cryopreservation are due to cell damage and intracellular 
oxidative stress throughout the preservation. The freezing 
process in cryopreservation may cause ice formation that 
damages the cells. At rapid cooling rate, intracellular 
ice crystals cause mechanical rupture of cell structure. 
Contrarily, slower rate of freezing causes ice crystal 
formation in the extracellular space resulting in increased 
osmolality since free water molecules may be incorporated 
into the ice crystals. Loss of free water molecules result 
in hyperosmolality and cell dehydration (Rowley 1992). 
Formation of ice crystals also leads to oxidative stress 
in the cells due to mitochondrial injury that disrupts 
oxidative metabolism in cells. Oxidative stress during 
cryopreservation additionally might incur from osmotic 
stress and increased cellular metabolism. Osmotic stress 
is a condition that causes sudden change in movement of 
free water across the cell membrane due to difference in 
osmotic gradient between intracellular and extracellular 
space. Withdrawal of water molecules causes cells to shrink 
and rupture. Osmotic stress also activates generation of 
superoxide anions by activating NADPH oxidase (Orrenius 
et al. 2007). 
 This study also showed a significant increase in cell 
viability in cryopreserved HSCs supplemented with 0.5 
μM and 2.0 μM NAC compared to control group after 48 
h cryopreservation. This finding is in agreement with a 
previous study that showed supplementation with NAC at 
0.25 μM and 0.5 μM suppressed cellular ROS levels and 
improved cell viability (Abdul Hamid et al. 2018). HSCs 
cryopreserved with 0.25 μM NAC also showed a significant 
increase in cell viability after 2 weeks cryopreservation. 
Addition of NAC as antioxidant supplement prior to 
cryopreservation might boost antioxidant system and 
reduce potential cell damage in HSCs. This finding is also 
consistent with several established studies that concluded 
antioxidants can not only mitigate oxidative stress, but 
also improve stem cell survival and improve their potency 
and differentiation (Shaban et al. 2017). In a previous 
study, Roselle supplementation as antioxidant with bone-
marrow-derived HSCs induced a significant increase in GSH 
level and SOD activity in HSCs (Abdul Hamid et al. 2014). 
N-acetylcysteine is a potent antioxidant due to its ability 
to scavenge ROS and inhibit cellular damage and apoptosis 
driven by ROS. However, in this study, NAC was only able 
to improve cell viability at higher concentrations after 48 
h and 2 weeks cryopreservation. NAC at 0.5 μM and 2.0 
μM concentration were only efficient in increasing cell 
viability after short term cryopreservation. At longer term 
cryopreservation, a higher concentration of NAC is required 
to reduce cellular damage and minimize excessive ROS-
driven oxidative stress. This is in line with findings from 
a study that reported NAC reduces the rate of chromosomal 
aberrations in HSCs (Liu et al. 2012) and greater CD34+ 
cells were harvested from ex vivo culture of cord blood 
supplemented with NAC (Fan et al. 2008). 
 To date, most of the reported studies concerning the 
use of antioxidant as cryopreservative agent are mostly 
applied for preservation of embryos, spermatozoa and 
embryonic stem cells (Isachenko et al. 2013; Zhou 2004); 
with limited reports regarding the preservation of HSCs are 
available. Previous studies had shown that a combination of 
the bio-antioxidant catalase and the membrane stabilizer; 
trehalose in the conventional freezing mixture affords 
better cryoprotection to hematopoietic progenitor cells 
(Sasnoor et al. 2003) and greater preservation of mice bone 
marrow cells was achieved in the presence of antioxidant 
supplements (Limaye 1997). However, the influenced of 
cryopreservation time-points on the cell recovery post-
thawed cryopreservation deserve further investigation as 
no similar study with regards to time-points effect has been 
reported. 
 On antioxidant status analysis, this study showed 
a statistically significant increase in GSH level among 
cryopreserved hematopoietic stem cells supplemented 
with NAC after 48 h, 2 weeks and 8 weeks cryopreservation 
1944 
compared to the pre-cryopreserved cells. However, 
there is no significant increase in SOD activities after 
cryopreservation even with NAC supplementation at all 
concentrations. This finding is consistent with reports 
of Abdul Hamid et al. (2018) whereby different HSCs-
progenitor cells are suggested to acquire different antioxidant 
system response in presence of NAC supplementation. 
Meanwhile, previous report indicated that antioxidant 
supplementation caused no significant alteration on the GSH 
level and SOD activity of post-thawed sperm cells (Bucak 
et al. 2009). The antioxidant system plays an important 
role in cellular protection against damage and potential 
oxidative stress. It is also important for development of 
immune response (Bounous & Molson 2003). NAC has been 
used in clinical settings for more than 30 years in treatment 
and management of HIV infection, cancer and heart disease. 
Irabbasi et al. (2016) reported that NAC supplementation 
does not only improve nutritional status among chronic 
obstructive pulmonary disease (COPD) patients but also 
increased plasma GSH level by 171% in these patients. NAC 
acts as an efficient antioxidant through its ability to reduce 
extracellular cystine to cysteine as well by acting as source 
of thiol group (-SH) metabolite. As free -SH source, NAC has 
ability to enhance endogenous glutathione-S-transferase 
(GST) activity, promote detoxification and act directly 
on ROS and prevent cellular oxidation (Kelly 1998). The 
significant increase in GSH level after NAC supplementation 
in cryopreserved HSCs in this study implies that NAC could 
acts as a precursor for intracellular GSH biosynthesis 
(Samuni et al. 2013). Hence, it is possible that due to 
high concentration of hydroperoxides generated after 
cryopreservation, a compensatory mechanism may have 
triggered the increase in GSH level in HSCs to facilitate ROS 
detoxification and reduce oxidative damage. 
 The presence of  intracel lular  ROS due to 
cryopreservation may cause cellular damage and disrupt 
cellular macromolecules through DNA damage, protein 
oxidation and lipid peroxidation as previously mentioned. 
Therefore, oxidative stress markers including MDA and PC 
were measured in this study. PC can be produced through 
oxidative cleavage of proteins by either α-amidation 
pathway or by oxidation of glutamyl side chains leading 
to formation of a peptide in which the N-terminal amino 
acid is blocked by an α-ketoacyl derivatives (Dalle-donne 
et al. 2003). Carbonyl group can also be introduced 
into protein by secondary reaction of the nucleophilic 
side chains of cysteine, histamine and lysine residues 
together with aldehyde molecules such as 4-hydroxy-
2-nonenal, malondialdehyde and 2-propenal produced 
during lipid peroxidation. PC level in cryopreserved 
cells was significantly increased both in presence or 
absence of NAC supplementation after 48 h, 2 weeks 
and 8 weeks cryopreservation, respectively, compared 
to the pre-cryopreservation group. This indicated that 
NAC had no effect in reducing protein oxidation caused 
by cryopreservation. Hence, the NAC supplementation is 
incapable of preventing or reducing formation of carbonyl 
group caused by the protein oxidation.
 Meanwhile, this study also showed a significant 
reduction in MDA level in cryopreserved cells supplemented 
with NAC after 2 weeks and 8 weeks cryopreservation as 
compared to pre-cryopreserved cells. MDA is generated 
from the ROS-driven cellular lipid peroxidation whereby 
lipid peroxidation can disrupt the membrane lipid 
bilayer arrangement and may inactivate membrane-
bound receptors and enzymes as well as increase tissue 
permeability (Birben et al. 2012). Hydroxyl (HO•) and 
hydroperoxyl (HO•2) radicals are the most prevalent type 
of ROS with ability to cause lipid peroxidation. These 
hydroperoxides however can be decomposed through 
two-electron reduction by glutathione peroxidase. 
Hence, this explained the increase in level of intracellular 
GSH as discussed earlier as compensatory response to 
redox signalling reaction towards lipid peroxidation. 
Generation of MDA from lipid peroxidation inactivates 
numerous cellular proteins by forming protein cross-
linkages. An effective antioxidant system is required 
for reducing such damages, and supplementation with 
NAC in this study has helped to increase the GSH level. In 
this study, reduced level of MDA observed after 2 and 8 
weeks cryopreservation suggested that NAC might help in 
reducing MDA level via lipid peroxidation chain inhibition 
after long term but fails to inhibit such reaction at short 
term cryopreservation (48 h). 
 The ability of NAC to reduce oxidative damage on stem 
cells in various experimental studies has been documented 
with most of the reported studies are largely based on in 
vitro observation (Shaban et al. 2007). Fatima et al. (2017) 
reported that NAC abrogated H2O2 induced oxidative-stress 
of Whartonʼs Jelly (WJ) derived Mesenchymal stem cells 
(WJ-MSCs) by restoring the activity of GSH, SOD and CAT, 
along with reduced level of MDA. Previous studies have 
also shown that NAC able to protect oxidative injury 
mediated by H2O2 on diabetic mouse derived mesenchymal 
stem cells (Ali et al. 2016) and germ cells (Maheshwari et 
al. 2011) as well as able to decrease oxidative stress, rescue 
the decline in cellular properties induced by long-term in 
vitro culture and promote hematopoietic differentiation 
of induced pluripotent stem cells (iPSCs) (Berniakovich 
et al. 2012). Recently, studies also reported that NAC 
supplementation able to protects dental tissue stem cells 
against oxidative stress in vitro (Martacic et al. 2018) and 
reduced oxidative stress markers (MDA and PC) in cisplatin 
- induced toxicity in rat brain (Abdel-Wahab & Moussa 
2019). Despite of these reports, the cryoprotective effect 
of NAC specific for HSCs cryopreservation at differential 
time points concerning the qualitative and quantitative 
outputs has not been fully elucidated. Thus, the findings 
from present study could provide additional information 
concerning the role of NAC for HSCs cryopreservation that 
can potentially improve the cryopreservation approach.
CONCLUSION
Overall, it can be concluded that cryopreservation impaired 
the viability and promote greater protein oxidation (PC). 
  1945
NAC showed potential to improve cell viability and 
improved antioxidant capacity (GSH); all of which are 
influenced by the cryopreservation’s time-point and NAC 
concentrations. Further study is required to establish the 
conclusion.
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